The possible roles of hyperlipidemia and mononuclear cells in glomeruli in puromycin aminonucleoside nephrosis in rats.
The possibility that hyperlipidemia and an increase of mononuclear cells in the glomeruli could participate in the pathogenesis of minimal change glomerulopathy was evaluated in puromycin aminonucleoside (PAN) nephrosis in rats. Significant increases in intraglomerular CD4-, IL-2-receptor (R)- and ED-1-positive cells were found in PAN rats. Urinary protein excretion and mononuclear cells in the glomeruli of 1% cholesterol diet-fed rats significantly increased, compared with standard diet feeding. Moreover, administration of a subnephrogenic dose of PAN in cholesterol diet-fed rats substantially increased urinary protein excretion and mononuclear cells in the glomeruli. Additionally, antihyperlipidemia agents and immunosuppressive agents prevented urinary protein excretion and increases of CD4-, IL-2R- and ED-1-positive cells in the glomeruli of PAN nephrotic rats. Monoclonal antibodies directed against these cells also prevented urinary protein excretion. These results suggest that CD4-, IL-2R- and ED-1-positive cells and hyperlipidemia are involved in the progression, but not the pathogenesis, of PAN.
Hattori
T
T
Department of Pharmacology, Meijo University, Nagoya, Japan.
Nagamatsu
T
T
Ito
M
M
Suzuki
Y
Y
D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology; D001379:Azathioprine / Q000494:pharmacology; D015496:CD4-Positive T-Lymphocytes / Q000378:metabolism / Q000473:pathology; D002792:Cholestyramine Resin / Q000494:pharmacology; D002994:Clofibrate / Q000031:analogs & derivatives / Q000494:pharmacology; D016572:Cyclosporine / Q000494:pharmacology; D006949:Hyperlipidemias / Q000150:complications*; D000960:Hypolipidemic Agents / Q000494:pharmacology; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007678:Kidney Glomerulus / Q000473:pathology*; D007963:Leukocytes, Mononuclear / Q000473:pathology*; D008297:Male; D009401:Nephrosis / Q000139:chemically induced / Q000209:etiology / Q000473:pathology*; D011507:Proteinuria / Q000209:etiology / Q000517:prevention & control / Q000652:urine; D011692:Puromycin Aminonucleoside; D051381:Rats; D017207:Rats, Sprague-Dawley; D015375:Receptors, Interleukin-2 / Q000378:metabolism
D000924:Anticholesteremic Agents; D000960:Hypolipidemic Agents; D007166:Immunosuppressive Agents; D015375:Receptors, Interleukin-2; D002792:Cholestyramine Resin; D011692:Puromycin Aminonucleoside; D016572:Cyclosporine; D002994:Clofibrate; C003278:simfibrate; D001379:Azathioprine